Evidence map›Paper›PMID 36157971›Full record

ArticleCanadian respiratory journal2022

Evaluating the Factors Affecting COVID-19 Patients' Mortality in Arak in 2020.

Hossein Mazaherpour, Masoumeh Soofian, Elham Farahani, Ahmad Saebbian, Mostafa Etebari, Sakineh Mazaherpour, Fatemeh Ashrafian, Amitis Ramezani

Open access · goldAbstract read
In one paragraph

Article in Canadian respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hossein MazaherpourArak University of Medical Sciences, Arak, Iran.ORCID 0000-0001-8609-0702
Masoumeh SoofianArak University of Medical Sciences, Arak, Iran.ORCID 0000-0002-8564-3659
Elham FarahaniArak University of Medical Sciences, Arak, Iran.ORCID 0000-0002-7904-8247
Ahmad SaebbianArak University of Medical Sciences, Arak, Iran.ORCID 0000-0002-2129-5640
Mostafa EtebariArak University of Medical Sciences, Arak, Iran.ORCID 0000-0002-5713-5614
Sakineh MazaherpourTreatment Management of Social Security Organization of Khuzestan Province, Mahshahr, Iran.ORCID 0000-0002-6963-0217
Fatemeh AshrafianClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.ORCID 0000-0001-8260-100X
Amitis RamezaniClinical Research Department, Pasteur Institute of Iran, Tehran, Iran.ORCID 0000-0003-3502-8524
Arak University of Medical Sciences · IRPasteur Institute of Iran · IRIslamic Azad University Mahshahr · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has been a leading cause of death in the world in the last few years. This study has investigated various causes and risk factors that may lead to death due to this disease. Methods: From June to October 2020, 98 expired and 196 recovered patients were studied for risk factors, underlying diseases, and laboratory findings that could lead to disease progression and mortality. Results: There was a significant relationship in terms of blood pressure, age, oxygen saturation, tachycardia, tachypnea, the interval between the onset of symptoms and hospitalization, diabetes mellitus, lung disease, cardiovascular disease, history of opium abuse, C-reactive protein, white blood cell, lymphocytes, hemoglobin, creatinine elevation, elevated liver enzyme, creatine phosphokinase, lactate dehydrogenase, ferritin, D-dimer, troponin, prothrombin time, international normalized ratio, intensive care unit admission days, arrhythmia, sepsis, acute respiratory distress syndrome, acute kidney injury (AKI), and the type of antiviral and antibiotic therapy between the two groups of patients. Conclusions: Mortality due to COVID-19 is affected by various causes such as age, underlying diseases, and complications that may occur in the course of the disease (e.g., arrhythmia, myocardial infarction, and AKI). By accurately identifying these causes and risk factors, we can prevent these complications and the mortality from COVID-19.

Indexed as

Acute Kidney InjuryCOVID-19Anti-Bacterial AgentsAntiviral AgentsC-Reactive ProteinCreatine KinaseCreatinineFerritinsHumansL-Lactate DehydrogenaseRetrospective StudiesRisk FactorsSARS-CoV-2TroponinAnti-Bacterial AgentsAntiviral AgentsC-Reactive ProteinCreatine KinaseCreatinineFerritinsL-Lactate DehydrogenaseTroponin

Identifiers

PMID36157971
PMCPMC9507664
OpenAlexW4296078652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.